In order to investigate the nasal carcinogenic potential and nasal tumor modifying effects of 2,6-dimethylaniline (DMA), a metabolite of xylazine which is used for food-producing animals, male transgenic mice carrying the human prototype c-Ha-ras gene (rasH2 mice) were given diet containing 0 or 2000 ppm DMA for 51 weeks after initiation with/without 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Their non-transgenic CB6F1 littermates (non-Tg mice) were also treated in the same manner. Histopathologically, in rasH2 mice, the incidences of inflammations, respiratory metaplasias of the olfactory epithelium, and hyperplasias of the respiratory epithelium in the NNK+DMA group significantly increased as compared with those in the NNK alone group. In both rasH2 mice and non-Tg mice, proliferative Bowman's glands were induced in the NNK alone, DMA alone, and NNK+DMA groups. The value for PCNA-positive index of proliferative Bowman's glands in the NNK+DMA group of rasH2 mice significantly increased as compared with the NNK alone case. In rasH2 mice, the incidence of adenomas (33%) in the NNK+DMA group that might be derived from proliferative Bowman's glands was slightly, but not significantly, higher than that in the NNK alone group. These results suggest that DMA promotes the development of nasal proliferative lesions in rasH2 mice. (J Toxicol Pathol 2003; 16: 41-47) 
Introduction
2,6-Dimethylaniline (DMA) is one of the major metabolites of xylazine, an α 2 -adrenergic receptor agonist with sedative, muscle relaxant and analgesic properties that is commonly used as a veterinary medicine to reduce aggressiveness in food-producing animals associated with livestock bleeding [1] [2] [3] . It is also found in tobacco smoke and as a major metabolite of the local anesthetic lidocaine 4 . In mutagenicity tests, DMA has been reported to be positive in mouse lymphoma cells, sister chromatid exchange, and chromosomal aberrations, although not in the Ame's tests [5] [6] [7] [8] . DMA produced carcinomas and papillary adenomas in the nasal cavity of both male and female rats fed diet containing 3000 ppm DMA for 2 years 9 . In addition, our previous twostage nasal carcinogenesis study of DMA in rats using Nbis(2-hydroxypropyl)nitrosamine (DHPN) as an initiator demonstrated that DMA has a tumor-promoting effect on the olfactory mucosa in the nasal cavity 10 . However, there is no report demonstrating that nasal tumors are also induced in mice by the long-term administration of DMA.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is one of the tobacco-specific nitrosamines and a potent procarcinogen in laboratory animals 14 . The activation of NNK may occur via α-hydroxylation, resulting in the formation of the promutagenic adduct O 6 -methylguanine. This methylguanine is known to have miscoding properties, causes for point mutations, and is hypothesized to be important in carcinogenesis of NNK [15] [16] [17] . NNK induces tumors of the nasal cavity, lung, liver, and pancreas in rats, but only the lung in mice [18] [19] [20] [21] [22] . However, in the nasal tissue, since O 6 -methylguanine-specific protein was found in the nuclei of sustentacular cells, Bowman's glands, respiratory epithelial cells, and serous glands of mice 23 , it can be considered that NNK also acts as an initiator in the nasal cavity of mice.
Mice are usually less susceptible to the induction of epithelial tumors of the nasal cavity than rats 24, 25 . On the other hand, it has been indicated that transgenic (Tg) mice carrying the human prototype c-Ha-ras gene (rasH2 mice) are much more susceptible to genotoxic carcinogens than their wild type littermates (non-Tg mice) 26, 27 . In addition, as described above, NNK was predicted to act as an initiator in the nasal cavity in rasH2 mice. Therefore, in the present study, the nasal carcinogenic potential and nasal tumor modifying effects of DMA were investigated using a unique two-stage nasal carcinogenesis model initiated with NNK in rasH2 mice.
Materials and Methods

Animals and chemicals
A total of 50 male CB6F1-TgHras2 (rasH2) mice and 50 male non-transgenic CB6F1 (non-Tg) littermates were obtained from the Central Institute for Experimental Animals (Kawasaki, Japan), at 6 weeks of age. All rasH2 and non-Tg mice were housed in a polycarbonate cage with white wood chips under barrier system conditions (room temperature, 23 ± 2°C; relative humidity, 55 ± 5%; and 12 hr light and dark cycle). This animal experiment was carried out following the guideline set out by the Guide for the Care and Use of Laboratory Animals in the National Institute of Health Sciences.
NNK and DMA were obtained from Toronto Research Chemicals (Toronto, Canada) and Wako Pure Chemical Industries (Osaka, Japan), respectively.
Experimental design
After 2 weeks acclimatization period, 30 rasH2 and non-Tg male mice received an intraperitoneal injection of 3 mg/mouse of NNK in physiological saline once a week for two weeks and other 20 rasH2 and non-Tg mice were given an intraperitoneal injection of physiological saline in the same manner at 8 weeks of age. Among the 20 rasH2 and non-Tg mice given physiological saline, eight rasH2 and non-Tg mice were allocated to Group 1 (Control) and the remainder to Group 2 (DMA alone). Twelve out of 30 NNK-initiated rasH2 and non-Tg mice were allocated to Group 3 (NNK alone) and the remainder to Group 4 (NNK+DMA). The rasH2 and non-Tg mice in Groups 1 and 3 were fed pulverized basal diet alone and those in Groups 2 and 4 the diet containing 2000 ppm DMA for 51 weeks. All animals were given tap water ad libitum.
Necropsy and light microscopic examination
Dead or moribund animals during the experimental period were subjected to a complete necropsy as soon as they were found. All surviving animals were euthanized by exsanguination under ether anesthesia at week 53. Nasal cavities were fixed with 10% neutral buffered formalin and decalcified in 5% formic acid solution. Using the upper incisor teeth, incisive papilla, and molar teeth as guides for trimming, three transverse sections were made through the nasal cavity, and the parts obtained were processed for histology after paraffin embedding. They were sectioned at 4-5 µm thick and stained with hematoxylin and eosin (HE) or periodic acid-Schiff (PAS) for light microscopic examinations.
Immunohistochemical staining was applied for nasal proliferative lesions in the NNK alone and NNK+DMA groups using antibody against proliferative cell nuclear antigen (PCNA). The sections were pretreated with a microwave for 10 min in citrate buffer and allowed to cool slowly to room temperature. The sections were treated with ortho-periodic acid solution for 30 min to block endogenous peroxidase activity, and non-specific binding proteins were blocked with casein. The sections were incubated with monoclonal antibody against PCNA (DAKO, Glostrup, Denmark) and then incubated with mouse immunoglobulin (DAKO). The dilutions of primary and secondary antibodies were 1:50 and 1:100, respectively. Immunolocalization was visualized using the PAP complex method with 3,3'-diaminobenzidine (DAB, Wako Pure Chemical Industries, Osaka, Japan) as the chromogen and hematoxylin for counterstaining. The cells in which nuclei were positive for PCNA immunostaining were counted as PCNA positive cells. The PCNA-positive index of nasal proliferative lesions was calculated as the ratios of positive cells per 100 cells.
Statistical analysis
The incidences of nasal proliferative lesions observed were analyzed with Fisher's exact test. The data of PCNApositive index of these lesions were given as mean and standard deviation, and differences were analyzed by Student's t test.
Results
The final body weights of rasH2 and non-Tg mice in the NNK, DMA alone, and NNK+DMA gr oup s were significantly lower than those in non-treated groups, those of rasH2 and non-Tg mice in the NNK+DMA groups being significantly lowered as compared with the NNK alone groups (Table 1) . After 23 weeks, 3 rasH2 mice treated with NNK alone or without any treatment, 2 rasH2 mice treated with DMA alone, 3 rasH2 mice treated with NNK+DMA and 2 non-Tg mice treated with NNK+DMA were found dead or became moribund (Table 1) .
Histopathologically, inflammations consisting of neutrophilic infiltrations in the dorsal olfactory epithelium (Fig. 1) were found in all of the NNK+DMA groups of rasH2 and non-Tg mice and in 4/12 non-Tg mice treated with DMA alone ( Table 2 ). All of the DMA alone and NNK+DMA groups in rasH2 and non-Tg mice disclosed respiratory metaplasias of the dorsal olfactory epithelium (Fig. 2) . All of the NNK, DMA alone and NNK+DMA groups had respiratory metaplasias of Bowman's glands (Fig. 3) . Proliferative Bowman's glands (Fig. 4) were observed in all of the treated rasH2 mice except for the non-treated mice and all of the non-Tg mice of the DMA alone and NNK+DMA groups. Nine of 12 non-Tg mice in the NNK alone group had the same lesion. The incidence of proliferative Bowman's glands in the DMA alone group of non-Tg mice significantly increased as compared with that in the nontreated group. Proliferative Bowman's glands were characterized by increased numbers of Bowman's glands consisting of cuboidal cells with luminal dilatation in the lamina propria of the olfactory mucosa. The incidence of hyperplasias of the respiratory epithelium (Fig. 5) in the NNK+DMA group significantly increased as compared with that in the NNK alone group. Hyperplasias of the respiratory epithelium were composed of focal small nests of glandular and/or papillary structures consisting of strong acidophilic cuboidal cells. In rasH2 mice, 2/9 of the NNK alone group and 5/15 of the NNK+DMA group had adenomas consisting of glandular and/or papillary growth patterns of cuboidal cells, projecting into the nasal lumen (Fig. 6) , and there were no significant differences in their incidence between them. In PAS staining, small to large numbers of PAS-positive granules in the cytoplasm were observed in proliferating cells of Bowman's glands and adenomas in the NNK+DMA group in rasH2 mice. Carcinomas were not found in any groups.
Immunohistochemically, the values of PCNA-positive indices of proliferative Bowman's glands in rasH2 mice were 2.20 ± 1.79 in the NNK alone group and 9.60 ± 3.44 in the NNK+DMA group. The PCNA-positive index of B o wm a n ' s g l a n d s in th e N NK +D MA g r o u p w as significantly higher than that in the NNK alone group. In adenomas, the values of PCNA-positive indices were 7.00 ± 5.66 in the NNK alone group and 5.50 ± 6.56 in the NNK+DMA group, there being no significant differences between these groups (Table 3) .
Discussion
It has been reported that DMA induced carcinomas and papillary adenomas in the nasal cavity of rats fed diet containing 3000 ppm DMA for 2 years 9 . In our two-stage nasal carcinogenesis study of DMA in rats initiated with DHPN, it has been also indicated that DMA exerted a tumorpromoting effect on the nasal cavity in rats 10 . In the present study, the incidence of adenomas in the NNK+DMA group of rasH2 mice was slightly, but not significantly, higher than that in the NNK alone group, but no significant differences were observed between these groups. Furthermore, hyperplasias of the respiratory epithelium were observed in the NNK+DMA group of rasH2 mice at high incidences, the values of PCNA-positive index of proliferative Bowman's glands in the NNK+DMA group being higher than those in the NNK alone group. These results suggest that DMA enhances proliferative activity in the respiratory epithelium and Bowman's glands. In our previous studies, small to large numbers of PAS-positive granules in cytoplasm were histopathologically detected in glandular hyperplasias, dysplastic foci, and adenomas 28 . Bowman's glands usually contain large amounts of neutral and acidic mucosubstances stained with PAS. In addition, in electron microscopy, desmosomes, dense secretory granules identical to those in normal Bowman's glands, basement membranes, and microvilli were detected in epithelial cells of these proliferative lesions. Therefore, the authors concluded that adenomas and carcinomas observed were probably derived from Bowman's glands and Bowman's glands were the tumor targets of DMA 28, 29 . We didn't perform ultrastructural examinations on adenomas observed in our study. However, our findings that PAS-positive granules were detected in adenomas of the NNK+DMA group and PCNA-positive index of proliferative Bowman's glands in this group was higher than that in the NNK alone group as well as the morphological resemblance to adenomas observed in our previous two-stage nasal carcinogenesis study in rats strongly suggest that adenomas observed in this study arise from Bowman's glands. If mice receive the diet containing 2000 ppm DMA for much longer time, adenomas derived from Bowman's glands may be induced more frequently, because of the enhanced proliferative activity of Bowman's glands. In our study, inflammatory findings were found in all of the NNK+DMA groups, but not in the NNK alone group. This result may suggest that such an inflammatory stimulation induces the enhanced cell proliferative activity of Bowman's glands resulting in a promoting effect. More detailed investigations on the relationship between tumor promoting effects of DMA and inflammations may be required.
It has been reported that rats are usually more susceptible to the induction of epithelial tumors of the nasal cavity than mice 24, 25 . This may be the major reason why DMA did not show any clear tumor-promoting effects on nasal carcinogenesis in this study. On the contrary, rasH2 mice seem to be a promising candidate as an animal model for the development of a rapid carcinogenicity testing system, but the data on the nasal carcinogenesis in rasH2 mice are limited in the number of references and it is still premature to make a final conclusion that rasH2 mice are less sensitive to the nasal carcinogenicity. In fact, in the present study, nasal adenomas were induced in treated rasH2 mice but not in non-Tg mice. Further studies are absolutely n e c e s s a r y t o c l a r i f y t h e s u s c e p t i b i l i t y o f n a s a l carcinogenicity in rasH2 mice.
Based on the present study and our previous studies, it is suggested that DMA has a tumor promoting effect in the nasal cavity resulting from the enhanced cell proliferation of Bowman's glands in both rats and mice 10 . However, the induction of nasal tumors was not observed in the DMA alone groups in the present study and our previous studies 10, 28, 29 . In addition, DMA levels in the blood of rats subjected to continuous administration of high doses of the parent compound of DMA, xylazine, remained under the detection limit 12 . Therefore, the likelihood of nasal carcinogenenic effects of DMA in consumers via the ingestion of edible tissues in the food-producing animals treated with xylazine is extremely low. 
